The new CMS monitoring policy for anemia drug reimbursement: Implications for providers

Dialysis and Transplantation

Volumn 35, Issue 2, 2006, Pages

  Levy Jr , Ralph ^a,b  

^a Frost Brown Todd   (United States)

^b D and T's Editorial Advisory Board ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; DIALYSIS; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFICACY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HEMATOCRIT; HUMAN; MEDICAID; MEDICARE; PATIENT CARE; PATIENT SAFETY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW;

EID: 33845483123     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)